home
작성자 : admin작성일 : 2018-05-10 10:51

에이치엘비 "리보세라닙 혈액암 완치사례 확인"

기사 자세히 보기  http://www.newstomato.com/ReadNews.aspx?no=823242

해당 논문 보기   

 An open label, single-armed, exploratory study of apatinib (a novel VEGFR-2 tyrosine kinase inhibitor) in patients with relapse


http://www.hlbkorea.com/resources/?uid=120&mod=document